EICHORCondition: Identification of Infants at Risk for Type 1 Diabetes · Sponsor: Helmholtz Zentrum München
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
This description comes directly from the study's public registry record.
Anette-Gabriele Ziegler · 0800-000 0018 · contact@gppad.org
Christiane Winkler · 0049-89-31873745 · contact@gppad.org
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Age: up to age 6 weeks * provided written informed consent by custodial parent Exclusion Criteria: \-
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Institut für Diabetesforschung, Helmholtz Zentrum München | Munich, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03316261